Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Genelux Corporation (GNLX)

Atara Biotherapeutics, Inc. and Genelux Corporation are both Biotechnology companies. Atara Biotherapeutics, Inc. and Genelux Corporation are of similar size ($82.4M and $79.9M). Genelux Corporation has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Atara Biotherapeutics, Inc. leads on 7 and Genelux Corporation on 6.

Valuation

Metric ATRA GNLX Biotechnology median
P/E n/m n/m 10.60
P/S 19.27 7.88 9.40
P/B n/m 5.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 17.68 6.97 9.02
Earnings yield (14.86%) (43.65%) (32.88%)
Free cash flow yield (17.62%) (32.38%) (23.13%)

Profitability

Metric ATRA GNLX Biotechnology median
Gross margin 91.38% (3.42%) 68.51%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (177.93%) (51.96%)
Return on assets (57.62%) (121.80%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA GNLX Biotechnology median
Revenue growth (TTM) (96.72%) — 6.76%
EPS growth (last fiscal year) 122.52% 9.47% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA GNLX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 2.39 4.97
Net debt to EBITDA (0.22) 0.44 1.01

Dividend

Metric ATRA GNLX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATRA GNLX Biotechnology median
Market cap 79.90m 82.35m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack